Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Statistics

Total Valuation

BOM:543064 has a market cap or net worth of INR 165.08 billion. The enterprise value is 167.05 billion.

Market Cap	165.08B
Enterprise Value	167.05B

Important Dates

The last earnings date was Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	382.57M
Shares Outstanding	n/a
Shares Change (YoY)	-0.36%
Shares Change (QoQ)	+2.22%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	23.36%
Float	137.93M

Valuation Ratios

The trailing PE ratio is 92.10 and the forward PE ratio is 60.44.

PE Ratio	92.10
Forward PE	60.44
PS Ratio	7.28
PB Ratio	4.09
P/TBV Ratio	6.53
P/FCF Ratio	111.21
P/OCF Ratio	44.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.12, with an EV/FCF ratio of 112.54.

EV / Earnings	93.20
EV / Sales	7.36
EV / EBITDA	39.12
EV / EBIT	69.70
EV / FCF	112.54

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.10.

Current Ratio	2.83
Quick Ratio	1.56
Debt / Equity	0.10
Debt / EBITDA	0.94
Debt / FCF	2.70
Interest Coverage	6.44

Financial Efficiency

Return on equity (ROE) is 3.84% and return on invested capital (ROIC) is 4.91%.

Return on Equity (ROE)	3.84%
Return on Assets (ROA)	2.67%
Return on Invested Capital (ROIC)	4.91%
Return on Capital Employed (ROCE)	4.71%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	18.72M
Profits Per Employee	1.48M
Employee Count	1,212
Asset Turnover	0.40
Inventory Turnover	1.29

Taxes

In the past 12 months, BOM:543064 has paid 569.20 million in taxes.

Income Tax	569.20M
Effective Tax Rate	27.49%

Stock Price Statistics

The stock price has decreased by -58.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-58.74%
50-Day Moving Average	386.92
200-Day Moving Average	574.35
Relative Strength Index (RSI)	51.84
Average Volume (20 Days)	439,549

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543064 had revenue of INR 22.69 billion and earned 1.79 billion in profits. Earnings per share was 4.68.

Revenue	22.69B
Gross Profit	16.06B
Operating Income	2.40B
Pretax Income	2.07B
Net Income	1.79B
EBITDA	4.27B
EBIT	2.40B
Earnings Per Share (EPS)	4.68

Balance Sheet

The company has 3.26 billion in cash and 4.00 billion in debt, with a net cash position of -745.10 million.

Cash & Cash Equivalents	3.26B
Total Debt	4.00B
Net Cash	-745.10M
Net Cash Per Share	n/a
Equity (Book Value)	40.34B
Book Value Per Share	102.03
Working Capital	11.82B

Cash Flow

In the last 12 months, operating cash flow was 3.68 billion and capital expenditures -2.20 billion, giving a free cash flow of 1.48 billion.

Operating Cash Flow	3.68B
Capital Expenditures	-2.20B
Depreciation & Amortization	1.87B
Net Borrowing	-1.13B
Free Cash Flow	1.48B
FCF Per Share	n/a

Margins

Gross margin is 70.79%, with operating and profit margins of 10.56% and 7.90%.

Gross Margin	70.79%
Operating Margin	10.56%
Pretax Margin	9.13%
Profit Margin	7.90%
EBITDA Margin	18.82%
EBIT Margin	10.56%
FCF Margin	6.54%

Dividends & Yields

BOM:543064 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.36%
Shareholder Yield	0.36%
Earnings Yield	1.09%
FCF Yield	0.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	6